Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 September 2022 | Story Rulanzen Martin | Photo Rulanzen Martin
Bartimea school outreach
Annemarie Le Roux and two of the learners from the Bartimea School for the Deaf and Blind.

It was a perfect Spring Day with laughter, cupcakes, and the brightest smiles on excited little faces of learners from the Bartimea School for the Deaf and Blind in front of the Main Building of the Bloemfontein Campus of the University of the Free State (UFS). The UFS Department of Deaf Studies and South African Sign Language hosted the school on 1 September 2022 for a day of learning, fun, and lots of games to kickstart #DeafAwarenessMonth. 

The relationship between the department and the school is stronger than ever, and after a two-year hiatus both staff and learners were basking in the excitement of the day. The school faced closure back in 2016 and it was in this year that the department and the student group Signals started a project to visit the school, which saw them participate in different activities with the learners. “We helped the school with the cleaning up of the school grounds and painting the playgrounds,” said Annemarie Le Roux, South African Sign Language lecturer at the UFS. 

UFS could set blueprint for outreach to Deaf communities 

The department and the UFS are in a unique position to set a blueprint for engaged scholarship with the Bartimea school in Thaba ’Nchu and the Thiboloha School for the Deaf and Blind in Phuthaditjhaba (formerly Qwaqwa). 

The Bartimea outreach is an important project for the department because it not only enables the students to put their teachings into practice but also demonstrates the engaged scholarship mandate of the UFS. Le Roux believes more teachers should be able to use SASL in schools, and the UFS could facilitate such training opportunities. “It would be wonderful if the university and the school could work together in engaged teaching and learning.” She added that leaners at the two schools sometimes do not get all the information they need when applying to universities. 

Le Roux thinks the relationship between Bartimea and the department could enable meaningful action to foster engaged citizenship. “We can help with fundraising, because the school is always in need of funding, as most parents cannot contribute to helping the school.” 

Putting teaching excellence into practice

This engagement with Bartimea allows students to put what they have learned in lecture halls into practice. “Students who attend the visits to the school or the school to the university understand more about the culture, and want to learn more and develop their language skills,” Le Roux said. “Before the COVID-19 pandemic we took our third-year and honours students to the school to give them access to the Deaf community.” Furthermore, the engagement helps students gain a better understanding of Deaf culture and sign language.

Also visit our Deaf Awareness Month webpage for more information.  

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept